19-51017267-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145888.3(KLK10):c.112C>A(p.Gln38Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000746 in 1,608,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_145888.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLK10 | NM_145888.3 | c.112C>A | p.Gln38Lys | missense_variant | 3/6 | ENST00000358789.8 | NP_665895.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLK10 | ENST00000358789.8 | c.112C>A | p.Gln38Lys | missense_variant | 3/6 | 1 | NM_145888.3 | ENSP00000351640.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000839 AC: 2AN: 238462Hom.: 0 AF XY: 0.0000153 AC XY: 2AN XY: 130700
GnomAD4 exome AF: 0.00000687 AC: 10AN: 1455946Hom.: 0 Cov.: 33 AF XY: 0.0000110 AC XY: 8AN XY: 724134
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2024 | The c.112C>A (p.Q38K) alteration is located in exon 3 (coding exon 2) of the KLK10 gene. This alteration results from a C to A substitution at nucleotide position 112, causing the glutamine (Q) at amino acid position 38 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at